Skip to content

Combining tenofovir with FTC or 3TC boosts chances of HBV suppression for people co-infected with HIV

Frailty increases the risk of fragility fractures in men living with HIV: data collected in routine HIV care can help predict risk

Couples study in Uganda finds no HIV infections from partners on antiretroviral therapy

Condoms used in one-in-four heterosexual encounters in the US

Tenofovir, atazanavir/ritonavir and Kaletra associated with kidney problems in patients taking HIV therapy

PrEP wars: debating pre-exposure prophylaxis in the gay community

Finances for the over-50s

Treatment as prevention: Experts in the UK agree it works

It's tough to make predictions